PATENT CLAIM ANALYSIS

Application Number: 16072992
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "250000"]

Abstract:
The present invention relates to a trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and a method for manufacturing the same. Specifically, the composition contains trabectedin and a first excipient, the first excipient being selected from one or more of monosaccharide or polylols. The preparation in the present invention has a stable quality, and can be applied to mass production.

Claim (Index 8):
The composition according to  claim 3 , wherein the weight ratio of trabectedin to the second excipient is 1:10 to 1:1000.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.46667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14901249', '14508488', '15144884', '13610335', '12746164']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7661535893434197
- 35 USC 102 Novelty (BERT): 0.5034275464928424
- Combined Prediction Score: 0.7398809850583621
- Mean Citation Score: 218.90102
- Max Citation Score: 226.23906
- Similarity Product: 147.7797114604855

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test